Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Myoclonic Seizures in Idiopathic Generalized Epilepsy
NCT00150774Phase 3Completed
- Sponsor
- UCB
- Start
- Nov 2001
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in idiopathic generalized epilepsy (IGE) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Responder rate in myoclonic (type IIB) seizures days at 16 weeks. Started Nov 2001; status: completed.
02
Drugs
levetiracetam
03
Conditions
idiopathic generalized epilepsy (IGE)
Beyond the preview
Go deeper on NCT00150774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150774.